Chatbot Implementation In The Clinical Informed Consent Process
M.D. Anderson Cancer Center
Summary
The purpose of this study is to determine the feasibility of implementing the chatbot "CoCo" in the IC process for research studies. We hypothesize that implementing a chatbot into the IC process will facilitate accurate information delivery and enhance participant comprehension and process satisfaction compared to traditional remote consent methods.
Description
Primary Objectives: • To determine the feasibility of implementing a chatbot-facilitated remote informed consent (IC) process. Secondary Objectives * To identify determinants of patient acceptance and usage of the chatbot. * To determine the accuracy and completeness of information delivered via the chatbot. * To determine the quality of the chatbot-facilitated remote IC process. * To determine the feasibility of using the chatbot for patient eligibility verification.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Ability to understand and willingness to provide informed consent. * Age ≥18 years. * Patients whose preferred language is English. * Patients who are being considered for enrollment in selected clinical research studies. Phase I will be initiated using the Clearinghouse protocol PA11-0852, a non-interventional biomarker study. Exclusion Criteria: N/A
Interventions
- OtherCoCo Chatbot
A patient-facing chatbot designed to obtain informed consent
Location
- UT MD AndersonHouston, Texas